Whole Body MRI in Oncology
Recruiting · NCT06895291 · Observational (researchers observe without assigning treatment) · Lead sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
View the official record on ClinicalTrials.gov →Interventions studied
Whole Body-Magnetic Resonance Imaging (WB-MRI)
What this trial is about
Multicenter, observational, prospective, study. All patients will be treated and monitored according to the local clinical practice. No additional procedures/patient visits in comparison with the usual clinical practice are planned for the study.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients candidate to WB-MRI according to clinical practice belonging to the study groups listed above.
- Participant is willing and able to give informed consent for participation in the study.
- Male or Female, aged ≥ 18 years.
- Life expectancy greater than 3 months.
Exclusion criteria
- Patients with MRI-unsafe prostheses and devices.
- Patients whose tests are of suboptimal quality, or whose test has been suspended, or is incomplete.
Where it is running
3 locations listed.
- IRCCS - Azienda Ospedaliero-Universitaria di Bologna - Policlinico di S. Orsola - Bologna, BO, Italy
- IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l. - Meldola, FC, Italy
- IRCCS Istituto Europeo di Oncologia S.r.l. - Milan, MI, Italy